Jan Peter Mattsson is an entrepreneur who founded Albireo Pharma, Inc., Albireo Ltd. and Albireo AB. Currently, he is Chief Scientific Officer & Managing Director-Sweden at Albireo Pharma, Inc. and Chief Operating Officer of Albireo AB (a subsidiary of Albireo Pharma, Inc.). Dr. Mattsson is also on the board of Toleranzia AB and Elobix AB.
He previously was Director, Chief Executive & Operating Officer at Albireo Ltd. and Associate Director at AstraZeneca AB.
Dr. Mattsson received a doctorate and an undergraduate degree from the University of Gothenburg.